Breaking News, Collaborations & Alliances

Plasticell and Sphere Fluidics Sign Research Collaboration

Will develop gene transduction technology designed to lead to safer and more efficient gene therapies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Plasticell, a biotechnology company using combinatorial cell culture technologies for optimization of cell and gene therapy manufacturing, has signed a collaboration agreement with Sphere Fluidics, a company specializing in single cell encapsulation and screening. Plasticell has used its proprietary Combinatorial Cell Culture (CombiCult) platform to develop inexpensive, high-efficiency gene transduction protocols as alternatives to commercial transfection reagents currently used in gene thera...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters